384 related articles for article (PubMed ID: 26080435)
1. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.
Salameh A; Lee AK; Cardó-Vila M; Nunes DN; Efstathiou E; Staquicini FI; Dobroff AS; Marchiò S; Navone NM; Hosoya H; Lauer RC; Wen S; Salmeron CC; Hoang A; Newsham I; Lima LA; Carraro DM; Oliviero S; Kolonin MG; Sidman RL; Do KA; Troncoso P; Logothetis CJ; Brentani RR; Calin GA; Cavenee WK; Dias-Neto E; Pasqualini R; Arap W
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8403-8. PubMed ID: 26080435
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts.
Lauer RC; Barry M; Smith TL; Thomas AM; Wu J; Du R; Lee JH; Rao A; Dobroff AS; Arap MA; Nunes DN; Silva IT; Dias-Neto E; Chen I; McCance DJ; Cavenee WK; Pasqualini R; Arap W
Elife; 2023 Jan; 12():. PubMed ID: 36645410
[TBL] [Abstract][Full Text] [Related]
3. miR-19a and miR-421 target PCA3 long non-coding RNA and restore PRUNE2 tumor suppressor activity in prostate cancer.
Bozgeyik E; Kocahan S; Temiz E; Bagis H
Mol Biol Rep; 2022 Jul; 49(7):6803-6815. PubMed ID: 34839449
[TBL] [Abstract][Full Text] [Related]
4. [Expression of PRUNE2 mRNA and its positive correlation with non-coding RNA PCA3 in leiomyosarcoma].
Yang JL; Cogdell D; Eddy J; Trent J; Price N; Zhang W
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):497-500. PubMed ID: 22967466
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer.
Salagierski M; Verhaegh GW; Jannink SA; Smit FP; Hessels D; Schalken JA
Prostate; 2010 Jan; 70(1):70-8. PubMed ID: 19760627
[TBL] [Abstract][Full Text] [Related]
6. PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells.
Lemos AE; Ferreira LB; Batoreu NM; de Freitas PP; Bonamino MH; Gimba ER
Tumour Biol; 2016 Aug; 37(8):11339-48. PubMed ID: 26960690
[TBL] [Abstract][Full Text] [Related]
7. PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.
Ferreira LB; Palumbo A; de Mello KD; Sternberg C; Caetano MS; de Oliveira FL; Neves AF; Nasciutti LE; Goulart LR; Gimba ER
BMC Cancer; 2012 Nov; 12():507. PubMed ID: 23130941
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese males.
Zhou W; Tao Z; Wang Z; Hu W; Shen M; Zhou L; Wen Z; Yu Z; Wu X; Huang K; Hu Y; Lin X
Exp Mol Pathol; 2014 Dec; 97(3):550-3. PubMed ID: 25445501
[TBL] [Abstract][Full Text] [Related]
9. Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors.
Soares JC; Soares AC; Rodrigues VC; Melendez ME; Santos AC; Faria EF; Reis RM; Carvalho AL; Oliveira ON
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46645-46650. PubMed ID: 31765118
[TBL] [Abstract][Full Text] [Related]
10. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
[TBL] [Abstract][Full Text] [Related]
11. A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
Neveu B; Jain P; Têtu B; Wu L; Fradet Y; Pouliot F
Oncotarget; 2016 Jan; 7(2):1300-10. PubMed ID: 26594800
[TBL] [Abstract][Full Text] [Related]
12. New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression.
Clarke RA; Zhao Z; Guo AY; Roper K; Teng L; Fang ZM; Samaratunga H; Lavin MF; Gardiner RA
PLoS One; 2009; 4(3):e4995. PubMed ID: 19319183
[TBL] [Abstract][Full Text] [Related]
13. Going viral? Linking the etiology of human prostate cancer to the
Teixeira AA; Marchiò S; Dias-Neto E; Nunes DN; da Silva IT; Chackerian B; Barry M; Lauer RC; Giordano RJ; Sidman RL; Wheeler CM; Cavenee WK; Pasqualini R; Arap W
EMBO Mol Med; 2017 Oct; 9(10):1327-1330. PubMed ID: 28751581
[TBL] [Abstract][Full Text] [Related]
14. GRP78 Participates in PCA3-regulated Prostate Cancer Progression.
Lin C; Wang J; Wang Y; Zhu P; Liu X; Li N; Liu J; Yu L; Wang W
Anticancer Res; 2017 Aug; 37(8):4303-4310. PubMed ID: 28739722
[TBL] [Abstract][Full Text] [Related]
15. Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA.
Drayton RM; Rehman I; Clarke R; Zhao Z; Pang K; Miah S; Stoehr R; Hartmann A; Blizard S; Lavin M; Bryant HE; Martens-Uzunova ES; Jenster G; Hamdy FC; Gardiner RA; Catto JW
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):268-75. PubMed ID: 25392181
[TBL] [Abstract][Full Text] [Related]
16. A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness.
Lai J; Moya L; An J; Hoffman A; Srinivasan S; Panchadsaram J; Walpole C; Perry-Keene JL; Chambers S; ; Lehman ML; Nelson CC; Clements JA; Batra J
Sci Rep; 2017 Dec; 7(1):16862. PubMed ID: 29203868
[TBL] [Abstract][Full Text] [Related]
17. Functional Titanium Carbide MXenes-Loaded Entropy-Driven RNA Explorer for Long Noncoding RNA PCA3 Imaging in Live Cells.
Wang S; Song W; Wei S; Zeng S; Yang S; Lei C; Huang Y; Nie Z; Yao S
Anal Chem; 2019 Jul; 91(13):8622-8629. PubMed ID: 31144498
[TBL] [Abstract][Full Text] [Related]
18. The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation.
Beckedorff FC; Ayupe AC; Crocci-Souza R; Amaral MS; Nakaya HI; Soltys DT; Menck CF; Reis EM; Verjovski-Almeida S
PLoS Genet; 2013; 9(8):e1003705. PubMed ID: 23990798
[TBL] [Abstract][Full Text] [Related]
19. FOXF2 Regulates PRUNE2 Transcription in the Pathogenesis of Colorectal Cancer.
Li T; Huang S; Yan W; Zhang Y; Guo Q
Technol Cancer Res Treat; 2022; 21():15330338221118717. PubMed ID: 35929169
[No Abstract] [Full Text] [Related]
20. MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a.
Zhang S; Li Z; Zhang L; Xu Z
Mol Med Rep; 2018 Jul; 18(1):202-208. PubMed ID: 29749452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
